This content is machine translated Dupilumab EU approval for severe chronic rhinosinusitis with polyposis nasi The monoclonal antibody dupilumab, which has already been approved by the European Medicines Agency (EMA) for the treatment of atopic dermatitis and asthma, is now also available for patients with…
View Post 3 min This content is machine translated Joint SSORL/SSAI Meeting Biologics in asthma and aluminum adjuvants in vaccines The fact that asthma is a very heterogeneous disease is especially true for patients with severe asthma. Additional new drugs are needed mainly for patients whose severe asthma is not…
View Post 8 min This content is machine translated Multiple Sclerosis Symposium Start therapy early to improve long-term outcome The Multiple Sclerosis Symposium at Inselspital in Bern provided a broad overview of the epidemiology, etiology, course, assessment, and current pharmacotherapy of the condition. There are exciting findings from basic…
View Post 4 min This content is machine translated Lung, kidney cancer and chronic myeloid leukemia What does modern clinical practice look like? At the DGHO Congress in Vienna, various aspects in clinical practice in non-small cell lung cancer (NSCLC), renal cell cancer (RCC) and chronic myeloid leukemia were addressed. In particular, the…
